Musashi-1 promotes cancer stem cell properties of glioblastoma cells via upregulation of YTHDF1.

Given the fact that both proteins are master regulators of gene expression, and both of them are unfavorable factors in GBM, we suggest that in any future studies aimed to uncover the prognostic value and therapy potential, these two proteins should be considered together.